Both ISRG and ABT closed 2025 on a strong note, but Intuitive Surgical's surging procedure growth and innovation may give it ...
I reiterate a 'Sell' rating on Intuitive Surgical with a fair value of $350 per share due to its hefty valuation. The Da Vinci 5 robot rollout in mid-2025 is a major catalyst, with significant growth ...
One of the biggest growth stories in medical devices is Intuitive Surgical, but don't overlook the opportunity ahead for this ...
4don MSN
Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins
Wall Street is overly focused on GLP-1 drugs even as this medical device maker continues to thrive.
Intuitive Surgical (NasdaqGS:ISRG) reported 19% year-over-year revenue growth in fiscal 2025 Q4. Growth was driven by higher procedure volumes and increased placements of da Vinci robotic systems. The ...
Intuitive Surgical's stock is poised to return over 60% in 2024, driven by strong tailwinds in the MedTech industry and elevated capital investments. The da Vinci 5 system has been well received, with ...
SUNNYVALE, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that ...
Competitors may try to dethrone the king of robotic surgery, but it will be an uphill battle if early feedback on da Vinci 5 is any indication. FDA cleared Intuitive Surgical's next-generation ...
Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results